Medical Device Network on MSN

Masimo secures FDA approval for OIRD detection on wearable patient monitor

The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.
Business Wire

Masimo SET ® Pulse Oximetry: Superior Performance, Worldwide Presence, Immeasurable Impact

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...
Nasdaq

GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform

CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse ...

Is Danaher (DHR) Using Masimo’s New FDA-Cleared AI Tool To Redefine Its Medtech Edge?

On 22 June 2026, Masimo, a Danaher company, received FDA 510(k) clearance for an AI-enabled opioid-induced respiratory ...
FierceBiotech

Philips, Masimo expand partnership after latter's pulse oximetry smartwatch launch

Philips and Masimo’s patient monitoring collaboration was a somewhat unlikely one when it began in 2016: Their agreement was announced in the same release that heralded the end of a years-long legal ...